Source:http://linkedlifedata.com/resource/pubmed/id/18416977
Switch to
| Predicate | Object |
|---|---|
| rdf:type | |
| lifeskim:mentions | |
| pubmed:issue |
2
|
| pubmed:dateCreated |
2008-4-17
|
| pubmed:abstractText |
A variety of modalities are available for the control of recurrent epistaxis in hereditary hemorrhagic telangiectasia (HHT). Laser ablation, in particular potassium-titanyl-phosphate (KTP), has gained popularity as it coagulates the telangiectasia with minimal peripheral tissue injury. Septodermoplasty (SDP) also can be performed in the day surgery setting. Telangiectasia recurred, necessitating repeated treatments. The frequency and interval between procedures is not well documented. The purpose of this study was to describe the frequency of surgical interventions for HHT patients and the impact of SDP.
|
| pubmed:language |
eng
|
| pubmed:journal | |
| pubmed:citationSubset |
IM
|
| pubmed:status |
MEDLINE
|
| pubmed:issn |
1050-6586
|
| pubmed:author | |
| pubmed:issnType |
Print
|
| pubmed:volume |
22
|
| pubmed:owner |
NLM
|
| pubmed:authorsComplete |
Y
|
| pubmed:pagination |
182-7
|
| pubmed:meshHeading |
pubmed-meshheading:18416977-Epistaxis,
pubmed-meshheading:18416977-Female,
pubmed-meshheading:18416977-Humans,
pubmed-meshheading:18416977-Laser Therapy,
pubmed-meshheading:18416977-Lasers, Solid-State,
pubmed-meshheading:18416977-Male,
pubmed-meshheading:18416977-Nasal Septum,
pubmed-meshheading:18416977-Retrospective Studies,
pubmed-meshheading:18416977-Telangiectasia, Hereditary Hemorrhagic,
pubmed-meshheading:18416977-Treatment Outcome
|
| pubmed:articleTitle |
The impact of septodermoplasty and potassium-titanyl-phosphate (KTP) laser therapy in the treatment of hereditary hemorrhagic telangiectasia-related epistaxis.
|
| pubmed:affiliation |
Rhinology Research Unit, Royal National Throat Nose and Ear Hospital, London WC1X 8DA, United Kingdom. richard@richardharvey.com.au
|
| pubmed:publicationType |
Journal Article
|